Shaping Tomorrow Responsible Innovation for a Brighter Future 2025
Page 27 of 34 · WEF_Shaping_Tomorrow_Responsible_Innovation_for_a_Brighter_Future_2025.pdf
Context
–Over half of the global population lacks health
service access, and rapid urbanization has
significantly strained urban health systems.
–Early disease detection can alleviate
downstream pressure on health systems.
However, the absence of user-friendly and
people-centred solutions leaves early risk
detection underused.
–As part of the CARDIO4Cities public-private
partnership (PPP) initiative, a screening
approach for early detection of hypertension has
been scaled in three Brazilian cities, resulting in
22% increased blood pressure measurements
and rapid improvement of blood pressure
control levels in the city populations.
Quality, affordable and accessible healthcare
provides the foundation for stable communities,
societies and economies. However, more than half
of the global population, or 4.5 billion people, do
not have full access to essential health services.43
In 2021, 20.5 million people died from
cardiovascular disease (CVD), many of those
prematurely before the age of 60.44 Most acute
cardiovascular (CV) events, such as heart attacks or
strokes, can be prevented through early detection
and adequate management of the main risk factors
for CVD. That makes proactive early detection
and prompt management of hypertension key to
reducing the burden of CVD on health systems.
Despite ample evidence on how to manage CVD
and great progress over the past decades, CVD is
on the rise – specifically in underserved populations.
Rapid urbanization, often leading to increased
sedentary lifestyles, decreased access to nutritious
diets, reduced social connections and higher
exposure to air pollution, fuels this increase in CVD.
Yet cities also offer new opportunities to become
drivers of CV population health. This makes cities
the ideal place to start.
How can urban health systems
inverse their current burden?
Health systems in cities need to address multiple
priorities, making it sometimes challenging to engage
health professionals and integrate new solutions
without disrupting existing workflows. Improving
population health requires a deep understanding
of the interaction between health systems, health
providers and their patients. To re-engineer urban CV health, new approaches have to engage end users
and take a people-centred approach to the design
phase of the innovation. This highlights the need to
bring early detection of CV risk closer to people and
provide it where and when they need it.
Currently, health systems face a significant gap
between the number of people at risk for CV health
risks and the number of diagnosed patients who are
managed for those risks.45 To reduce this gap, early
detection and subsequent adequate management
of people with CV risk is a priority and innovative
methods are needed, particularly in primary
healthcare settings, within high traffic venues in
the cities and within communities.
Accessible solutions for early
detection of CV risk relieve
pressure on the health system
Strengthening primary healthcare through early
detection and adequate management of CV risk
can lead to improved health outcomes, reduce the
burden on health systems and lower long-term
costs by avoiding complications, hospitalizations
or acute events of CVD.46
One opportunity to strengthen primary healthcare is
to take advantage of waiting times in health facilities
by offering CV risk screening to every person visiting
the facility (regardless of the reason) and expediting
doctor-patient consultations for those who screen
positive. In addition, primary healthcare and high-
traffic spaces in the city, such as vaccination sites,
street markets, football stadiums and schools, offer
possibilities to proactively reach people and guide
them into routine health services when needed.
Innovations alone have limited impact. To be effective,
they must be combined with critical enablers such
as PPPs that empower providers and patients to co-
create impactful, cost-effective and scalable solutions.
The “screening corner” as
an example of impactful
CV innovations
Within its CARDIO4Cities initiative, the Novartis
Foundation co-designed the “screening corner”
to accelerate early detection of CV risk factors.47
Developed, implemented and evaluated by a
consortium of public and private partners, this
tool focuses on accelerating the detection of CV
risk within and outside of primary care settings.
A screening corner is equipped with a blood
pressure measurement device, a digital stadiometer, Quality,
affordable
and accessible
healthcare provides
the foundation for
stable communities,
societies and
economies.
Shaping Tomorrow: Responsible Innovation for a Brighter Future
27
Ask AI what this page says about a topic: